Med Life Statistics

Total Valuation

Med Life has a market cap or net worth of RON 3.06 billion. The enterprise value is 4.67 billion.

Market Cap	3.06B
Enterprise Value	4.67B

Important Dates

The next estimated earnings date is Friday, February 28, 2025.

Earnings Date	Feb 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Med Life has 531.06 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	531.06M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	39.25%
Owned by Institutions (%)	26.32%
Float	322.60M

Valuation Ratios

The trailing PE ratio is 141.17 and the forward PE ratio is 54.95.

PE Ratio	141.17
Forward PE	54.95
PS Ratio	1.19
PB Ratio	6.97
P/TBV Ratio	n/a
P/FCF Ratio	106.99
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.87, with an EV/FCF ratio of 163.16.

EV / Earnings	215.27
EV / Sales	1.82
EV / EBITDA	12.87
EV / EBIT	35.32
EV / FCF	163.16

Financial Position

The company has a current ratio of 0.73, with a Debt / Equity ratio of 3.29.

Current Ratio	0.73
Quick Ratio	0.53
Debt / Equity	3.29
Debt / EBITDA	4.65
Debt / FCF	58.98
Interest Coverage	1.36

Financial Efficiency

Return on equity (ROE) is 2.55% and return on invested capital (ROIC) is 3.98%.

Return on Equity (ROE)	2.55%
Return on Assets (ROA)	3.05%
Return on Invested Capital (ROIC)	3.98%
Return on Capital Employed (ROCE)	6.52%
Revenue Per Employee	366,719
Profits Per Employee	3,102
Employee Count	6,997
Asset Turnover	0.95
Inventory Turnover	11.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +42.79% in the last 52 weeks. The beta is 0.80, so Med Life's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	+42.79%
50-Day Moving Average	5.89
200-Day Moving Average	5.60
Relative Strength Index (RSI)	44.75
Average Volume (20 Days)	35,691

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Med Life had revenue of RON 2.57 billion and earned 21.71 million in profits. Earnings per share was 0.04.

Revenue	2.57B
Gross Profit	1.26B
Operating Income	132.31M
Pretax Income	27.01M
Net Income	21.71M
EBITDA	282.59M
EBIT	132.31M
Earnings Per Share (EPS)	0.04

Full Income Statement

Balance Sheet

The company has 154.83 million in cash and 1.69 billion in debt, giving a net cash position of -1.53 billion or -2.89 per share.

Cash & Cash Equivalents	154.83M
Total Debt	1.69B
Net Cash	-1.53B
Net Cash Per Share	-2.89
Equity (Book Value)	513.63M
Book Value Per Share	0.83
Working Capital	-245.48M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 272.48 million and capital expenditures -243.84 million, giving a free cash flow of 28.64 million.

Operating Cash Flow	272.48M
Capital Expenditures	-243.84M
Free Cash Flow	28.64M
FCF Per Share	0.05

Full Cash Flow Statement

Margins

Gross margin is 48.99%, with operating and profit margins of 5.16% and 0.85%.

Gross Margin	48.99%
Operating Margin	5.16%
Pretax Margin	1.05%
Profit Margin	0.85%
EBITDA Margin	11.01%
EBIT Margin	5.16%
FCF Margin	1.12%

Dividends & Yields

Med Life does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	0.71%
FCF Yield	0.93%

Stock Splits

The last stock split was on September 1, 2023. It was a forward split with a ratio of 4.

Last Split Date	Sep 1, 2023
Split Type	Forward
Split Ratio	4

Scores

Med Life has an Altman Z-Score of 1.58. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.58
Piotroski F-Score	n/a